Take Five: It’s Q4 already?
Take Five: It’s Q4 already?
Similar Posts
ERM’s influence is growing as its ranks are shrinking
This piece is part of a series benchmarking bank enterprise risk management practices. Sign up for Risk Benchmarking emails here. Banks are leaning on their enterprise risk functions more heavily than a year ago, Risk Benchmarking’s latest study suggests – yet ERM teams have borne that added responsibility with a flat to shrinking core headcount,…
Old Pension Scheme option opens for select NPS employees: Who qualifies | Personal Finance
Certain Central government employees appointed on compassionate grounds may now be able to avail of the Old Pension Scheme (OPS), following a clarification issued by the Department of Pension and Pensioners’ Welfare (DoPPW). National Pension System (NPS) subscribers cannot switch back to OPS. The clarification addresses a long-standing issue faced by some compassionate…
Looming MiCA Deadline Shakes up European Crypto Exchanges
With just days until Europe’s Markets in Crypto-Assets (MiCA) regulations take full effect on July 1, Binance finds itself without the license needed to continue operating across the EU. The setback has triggered a scramble among licensed exchanges to win over its customers with bonuses, promotions, and cash incentives. Binance founder Changpeng Zhao criticized the…
Oil prices to hit $120 soon? Goldman Sachs makes big prediction as Hormuz concerns loom
Wall Street major Goldman Sachs has warned that Brent crude could surge to $120 per barrel if disruptions through the Strait of Hormuz, the world’s most critical oil transit route, persist, even as its base case assumes an eventual easing of tensions in the Middle East. Goldman Sachs expects Brent crude to average $80 per…
SpaceX entry drives index reshuffle as market concentration rises
What’s moving within the indexes The September ranking brought notable reclassifications across size and style segments. In the large-cap space, Seagate Technology Holdings and Western Digital Corp moved fully into mega-cap, reflecting durable gains tied to artificial intelligence demand. Moderna, meanwhile, initiated a packet from small-cap to mid-cap after surging more than 200% between the…
Biotech Movers: Modular Medical Jumps, InnovAge Revenue Up 16%, Pyxis Data On Deck, Dogwood In Focus
(RTTNews) – With heightened trade tensions between the U.S. and Canada and rising oil prices weighing on investor sentiment, U.S. stocks came under pressure on Tuesday. Against this backdrop, the SPDR S&P Biotech ETF (XBI), a broad benchmark for the U.S. biotechnology sector, declined 1.15% during regular trading hours but edged 0.09% higher in overnight…
